Abbott rides to the rescue with $5 Covid-19 test
The BinaxNow antigen test is fast and acceptably accurate – but above all, cheap.
Philips spends big in-house while Becton favours buying
The largest medtech companies have differing business development strategies, but tend to be on the same page on R&D spending.
Covid-19 antibody tests face a very specific problem
With the prevalence of coronavirus infection running at about 5%, test manufacturers and regulators alike will have to guard against false positives.
FDA authorises the first Covid-19 antibody test
Cellex wins the race to get the FDA’s buy-in for a blood test to pinpoint immunity.
Few groups have developed Covid-19 diagnostics – but this will change
The FDA is loosening its rules on the authorisation of diagnostic tests for the new coronavirus, but it is still some way behind Europe.
Becton Dickinson out for blood with new partnership
There is a ready market for blood tests that do not involve putting a needle to a vein. Can a new partnership meet the demand?
